½ÃÀ庸°í¼­
»óǰÄÚµå
1438126

¼¼°è ¸¶ÀÌÅ©·Î CT(ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ) ½ÃÀå ¿¹Ãø(-2030³â) : Á¦Ç°º°, ÄÄÆÛ³ÍÆ®º°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®

Micro Computed Tomography Market Forecasts to 2030 - Global Analysis By Product (In-Vivo and In-Vitro), Component, Application, End User and By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Stratistics Market Research Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200+ Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Stratistics MRC¿¡ µû¸£¸é ¼¼°èÀÇ ¸¶ÀÌÅ©·ÎÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ ½ÃÀåÀº 2023³â 2¾ï 3,180¸¸ ´Þ·¯¸¦ Â÷ÁöÇÏ¸ç ¿¹Ãø ±â°£ µ¿¾È CAGRÀº 11.0%·Î ¼ºÀåÇßÀ¸¸ç 2030³â¿¡´Â 4¾ï 8,140¸¸ ´Þ·¯¿¡ À̸¦ Àü¸ÁÀÔ´Ï´Ù.

¸¶ÀÌÅ©·Î CT(¸¶ÀÌÅ©·Î ÄÄÇ»ÅÍ ´ÜÃþ ÃÔ¿µ)´Â X ¼±À» »ç¿ëÇÏ¿© ÀÛÀº ¹°Ã¼ÀÇ »ó¼¼ÇÑ ´Ü¸é À̹ÌÁö¸¦ »ý¼ºÇÏ´Â °­·ÂÇÑ 3D À̹Ì¡ ±â¼úÀÔ´Ï´Ù. MicroCT´Â ½Ã·áÀÇ ³»ºÎ ±¸Á¶¿¡ ´ëÇÑ ±ÍÁßÇÑ ÅëÂû·ÂÀ» Á¦°øÇϸç Á¶»ç, ǰÁú °ü¸® ¹× Áø´Ü¿¡ µµ¿òÀÌ µË´Ï´Ù. ±× ´Ù¿ëµµ´Â Àç·á, »ý¹°ÇÐÀû »ùÇÃ, Àΰø¹° ¿¬±¸¿¡ ÇʼöÀûÀÌ¸ç °úÇÐ, ÀÇ·á ¹× ´Ù¾çÇÑ »ê¾÷ÀÇ ¹ßÀü¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

Tescan¿¡ µû¸£¸é UniTOM HRÀº ¸¶ÀÌÅ©·Î CT À̹Ì¡À» ÅëÇØ »ùÇÃÀÇ ³»ºÎ ±¸Á¶¸¦ °Ë»çÇÏ°í ´Ù¾çÇÑ È¯°æ¿¡¼­ »ùÇÃÀÇ °Åµ¿¿¡ ´ëÇÑ ´õ ±íÀº Áö½ÄÀ» ¿ä±¸ÇÏ´Â »ê¾÷ ¹× Çмú ¿¬±¸¿ø ¸ðµÎ¿¡°Ô ÀÌ»óÀûÀÔ´Ï´Ù.

¸¶ÀÌÅ©·Î CT ±â¼úÀÇ ²÷ÀÓ¾ø´Â Áøº¸

°ø°£ ºÐÇØ´É Çâ»ó, À̹Ì¡ ±â´É °¡¼ÓÈ­, È­Áú Çâ»ó µî Áö¼ÓÀûÀÎ ±â¼ú Çõ½ÅÀ¸·Î ÀÀ¿ë ºÐ¾ß´Â ¾÷°è Àü¹Ý¿¡ °ÉÃÄ È®´ëµÇ°í ÀÖ½À´Ï´Ù. Á¤È®ÇÑ Àç·á ºÐ¼®, ÀüÀÓ»ó ¿¬±¸ ¹× ºñÆÄ±« °Ë»ç¿¡ Ãֽбâ¼ú ±â´ÉÀ» Ȱ¿ëÇÏ´Â ¿¬±¸ÀÚ¿Í »ê¾÷°è·Î ½ÃÀå ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀÌ¿Í °°ÀÌ ¸¶ÀÌÅ©·ÎCT ±â¼úÀÇ ÁøÈ­´Â ±âÁ¸ÀÇ °úÁ¦¿¡ ´ëóÇÒ »Ó¸¸ ¾Æ´Ï¶ó »õ·Î¿î °¡´É¼º¿¡µµ ºÒÀ» ºÙ¿© ÅõÀÚ¸¦ ºÒ·¯¿À´Â ¿ªµ¿ÀûÀÎ Á¤¼¼¸¦ Ű¿ö ´Ù¾çÇÑ °úÇС¤»ê¾÷ ¿µ¿ª¿¡¼­ Áß¿äÇÑ À̹Ì¡ µµ±¸·Î¼­ÀÇ ÅëÇÕÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

´ëü À̹Ì¡ ±â¼ú°úÀÇ °æÀï

ƯÁ¤ ¿ä±¸ »çÇ׿¡ µû¶ó »ç¿ëÀÚ´Â ´ëü ¾ç½ÄÀ» ¼±ÅÃÇÏ°í ¸¶ÀÌÅ©·Î CT äÅÃÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. °¢ À̹Ì¡ ±â¼ú¿¡´Â ÀåÁ¡°ú ÇѰ谡 ÀÖÀ¸¸ç ´ëü ±â¼úÀÇ ÀåÁ¡ÀÌ ÀÎ½ÄµÇ¸é ¸¶ÀÌÅ©·Î CT¿¡¼­ÁÖÀǸ¦ ±â¿ïÀÏ ¼ö ÀÖ½À´Ï´Ù. ÀÌ °æÀïÀº ƯÈ÷ ´ëü ±â¼úÀÌ ÀåÁ¡À» °¡Áø ¿ëµµ¿¡¼­ ½ÃÀå ¼ºÀåÀ» µÐÈ­½ÃÄÑ ¸¶ÀÌÅ©·ÎCT ½ÃÀå Á¡À¯À²°ú Æ÷Áö¼Å´×¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ½ÃÀåÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

3D À̹Ì¡¿¡ ´ëÇÑ ÀÎ½Ä Çâ»ó

»ê¾÷°è¿Í ¿¬±¸ ºÎ¼­°¡ ³»ºÎ ±¸Á¶¸¦ Á¤È®ÇÏ°Ô ºÐ¼®Çϱâ À§ÇÑ »ó¼¼ÇÏ°í °íÇØ»óµµ 3D ½Ã°¢È­ÀÇ ÀåÁ¡À» ÀνÄÇÔ¿¡ µû¶ó ¸¶ÀÌÅ©·Î CT ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. Àç·á °úÇÐ, ÀüÀÓ»ó ¿¬±¸, ÇコÄɾî, »ê¾÷¿ë ÀÀ¿ë ºÐ¾ß¿¡¼­ ³Î¸® äÅÃµÈ °ÍÀº Á¾ÇÕÀûÀÎ ÅëÂû·ÂÀ» Á¦°øÇÏ´Â µ¥ ÀÖ¾î ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ´Â °ÍÀ» ¹Ý¿µÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÀǽÄÀÇ °íÁ¶´Â ±â¼úÀÇ Áøº¸¿Í ¿¬±¸ ÀÚ±Ý Áõ°¡¸¦ ÃËÁøÇÏ°í ¸¶ÀÌÅ©·ÎCT¸¦ ´Ù¾çÇÑ ºÐ¾ß¿¡¼­ÀÇ ºñħ½ÀÀû À̹Ì¡ ¼Ö·ç¼ÇÀÇ Áß¿äÇÑ ´ã´çÀÚ·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

Á¦ÇÑµÈ ½Ã¾ß ¹× »ùÇà ũ±â

´ë±Ô¸ð »ùÇÃÀÇ Á¾ÇÕÀû À̹Ì¡ÀÌ ÇÊ¿äÇÑ ¿¬±¸ÀÚ ¹× »ê¾÷°è´Â ´ëü ±â¼úÀ» ¼±ÅÃÇÒ ¼ö ÀÖÀ¸¸ç ¸¶ÀÌÅ©·Î CT ä¿ëÀÌ Á¦ÇÑµÉ ¼ö ÀÖ½À´Ï´Ù. ´Ù¾çÇÑ »ùÇà »çÀÌÁî¿¡ ´ëÀÀÇÏ´Â °úÁ¦´Â ¸¶ÀÌÅ©·ÎCTÀÇ ´Ù¾ç¼ºÀ» ÀúÇϽÃ۰í, º¸´Ù ³ÐÀº ¹üÀ§ÀÇ Ç¥º» Ä¡¼ö¿¡ ´ëÀÀÇÒ ¼ö ÀÖ´Â À̹Ì¡ ¼Ö·ç¼Ç°úÀÇ °æÀï¿¡ ¿µÇâÀ» ÁÖ¾î ½ÃÀåÀÇ ¼ºÀåÀ» ¹æÇØÇÕ´Ï´Ù.

COVID-19ÀÇ ¿µÇâ

°ø±Þ¸Á È¥¶õ, ÇÁ·ÎÁ§Æ® Áö¿¬, ¿¹»ê Á¦¾àÀº Àåºñ ±¸¸ÅÀÇ µÐÈ­·Î À̾îÁý´Ï´Ù. ½ÇÇè½ÇÀº Æó¼â¿¡ Á÷¸éÇϰí ÇʼöÀûÀÎ ¿¬±¸¸¦ ¿ì¼±½ÃÇϱ⠶§¹®¿¡ ƯÁ¤ ÀüÀÓ»ó ¿¬±¸ ¹× Àç·á ¿¬±¸¿Í °°Àº ºñÀÀ±Þ ÀÀ¿ë ºÐ¾ß¿¡ ´ëÇÑ ¼ö¿ä°¡ °¨¼ÒÇϰí ÀÖ½À´Ï´Ù. ÃâÀå Á¦Çѵµ ÇöÀå ¼³Ä¡¿Í À¯Áöº¸¼ö¸¦ ¹æÇØÇß½À´Ï´Ù. °æÁ¦ ºÒÈ®½Ç¼º°ú ¿¬±¸ºñ °¨¼Ò´Â ´õ¿í ±î´Ù·Î¿î ȯ°æÀ» Á¶ÀåÇß½À´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È ÁöÁúÇÐÀû ¿¬±¸ ºÎ¹®ÀÌ ÃÖ´ëÈ­µÉ Àü¸Á

ÁöÁúÇÐ ºÎ¹®Àº ¾Ï¼®°ú ¹Ì³×¶öÀÇ ±¸Á¶ ºÐ¼®¿¡¼­ ºñÆÄ±« À̹Ì¡¿¡ ´ëÇÑ ¼ö¿ä ÃËÁøÀ¸·Î À¯¸®ÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ¸¶ÀÌÅ©·ÎCT ±â¼úÀº ÁöÁú Á¶»ç¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϸç ÁöÇÏ Æ¯Â¡, °ø±Ø·ü ¹× Á¶¼ºÀ» Á¶»çÇϱâ À§ÇÑ »ó¼¼ÇÑ 3D À̹ÌÁö¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ ¾ÖÇø®ÄÉÀ̼ÇÀº ÁöÃþ ÀÌÇØ, Àú·ùÃþ Ư¼ºÈ­ ¹× ȯ°æ Æò°¡¿¡¼­ ÁöÁú °úÇÐÀÚ¸¦ Áö¿øÇÏ°í ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇÕ´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È ¿µ»ó Áø´Ü ½ÇÇè½Ç ºÐ¾ß°¡ °¡Àå ³ôÀº CAGRÀÌ ¿¹»óµË´Ï´Ù.

À̹Ì¡ ½ÇÇè½Ç ºÎ¹®Àº ÷´Ü À̹Ì¡ ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGR ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ÀÌ ½ÇÇè½ÇÀº ÀÇÇÐ, Ä¡°ú, ÀüÀÓ»ó ¿¬±¸ µîÀÇ ºÐ¾ß¿¡¼­ Á¤¹ÐÇÏ°í ºñħ½ÀÀûÀÎ À̹Ì¡¿¡ ¸¶ÀÌÅ©·Î CT¸¦ Ȱ¿ëÇÕ´Ï´Ù. °íÇØ»óµµ 3D À̹ÌÁö¸¦ Á¦°øÇÒ ¼ö ÀÖ´Â ÀÌ ±â¼úÀº Áø´Ü Á¤È®µµ¿Í ¿¬±¸ Áøº¸¿¡ ±â¿©ÇÏ¿© ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÕ´Ï´Ù.

ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇÏ´Â Áö¿ª

¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¬±¸ Ȱµ¿ Áõ°¡, »ê¾÷È­ ¹× ±â¼úÀÇ ¹ßÀüÀ¸·Î ¿¹Ãø ±â°£ µ¿¾È ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Áß±¹, ÀϺ», Çѱ¹ µîÀÇ ±¹°¡µéÀº Àç·á°úÇÐ, »ý¹°ÀÇÇבּ¸, °ø¾÷°Ë»çÀÇ ¿ëµµ È®´ë·Î ÁÖ¿ä °øÇå±¹ÀÌ µÇ°í ÀÖ½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀåÀº °úÇÐ ºÐ¾ß¿Í »ê¾÷¿¡ °ÉÄ£ ´Ù¾çÇÑ ÀÀ¿ë ºÐ¾ß¿¡ ÈûÀÔ¾î Áö¼ÓÀûÀÎ ¹ßÀü ż¼¸¦ À¯ÁöÇϰí ÀÖ½À´Ï´Ù.

CAGRÀÌ °¡Àå ³ôÀº Áö¿ª:

ºÏ¹Ì´Â ƯÈ÷ ¹Ì±¹°ú ij³ª´Ù¿¡¼­ ¿¬±¸°³¹ß¿¡ ¿Õ¼ºÇÑ ÅõÀÚ¸¦ ÅëÇØ ¸¶ÀÌÅ©·ÎCT ½Ã½ºÅÛÀÇ ±â¼ú Çõ½Å°ú ±â¼úÀû Áøº¸¸¦ µÞ¹ÞħÇϱ⠶§¹®¿¡ ¿¹Ãø ±â°£ µ¿¾È CAGRÀÌ °¡Àå ³ô¾ÆÁú °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Ç×°ø¿ìÁÖ, ÀÚµ¿Â÷ µîÀÇ »ê¾÷Àº ǰÁú°ü¸® ¹× Àç·áºÐ¼®¿¡ ¸¶ÀÌÅ©·ÎCT¸¦ Ȱ¿ëÇϰí ÀÖ½À´Ï´Ù. °úÁ¦°¡ ÀÖ´Â °Í, ºÏ¹ÌÀÇ ¸¶ÀÌÅ©·Î CT ½ÃÀåÀº ´Ù¾çÇÑ ¿ëµµ¿¡ ÀÇÇØ °è¼ÓÀûÀÎ È®´ë°¡ Àü¸ÁµÇ°í ÀÖ½À´Ï´Ù.

¹«·á ÁÖ¹®À» ¹Þ¾Æ¼­ ¸¸µå´Â ¼­ºñ½º:

ÀÌ º¸°í¼­¸¦ ±¸µ¶ÇÏ´Â °í°´Àº ´ÙÀ½ ¹«·á ¸ÂÃã¼³Á¤ ¿É¼Ç Áß Çϳª¸¦ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Ãß°¡ ½ÃÀå ±â¾÷ÀÇ Á¾ÇÕÀû ÇÁ·ÎÆÄÀϸµ(3°³»ç±îÁö)
    • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®(3°³»ç±îÁö)
  • Áö¿ª ¼¼ºÐÈ­
    • °í°´ÀÇ °ü½É¿¡ ÀÀÇÑ ÁÖ¿ä±¹ ½ÃÀå Ã߰衤¿¹Ãø¡¤CAGR(ÁÖ: Ÿ´ç¼º È®Àο¡ µû¸§)
  • °æÀï º¥Ä¡¸¶Å·
    • Á¦Ç° Æ÷Æ®Æú¸®¿À, Áö¸®Àû Á¸Àç, Àü·«Àû Á¦ÈÞ¿¡ ±â¹ÝÇÑ ÁÖ¿ä ±â¾÷ º¥Ä¡¸¶Å·

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼­¹®

  • °³¿ä
  • ÀÌÇØ°ü°èÀÚ
  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • µ¥ÀÌÅÍ ºÐ¼®
    • µ¥ÀÌÅÍ °ËÁõ
    • Á¶»ç Á¢±Ù
  • Á¶»ç ¼Ò½º
    • 1Â÷ Á¶»ç ¼Ò½º
    • 2Â÷ Á¶»ç ¼Ò½º
    • ÀüÁ¦Á¶°Ç

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • À§Çù
  • Á¦Ç°ºÐ¼®
  • ÀÀ¿ëºÐ¼®
  • ÃÖÁ¾ »ç¿ëÀÚ ºÐ¼®
  • ½ÅÈï ½ÃÀå
  • COVID-19ÀÇ ¿µÇâ

Á¦4Àå Porter's Five Forces ºÐ¼®

  • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
  • ±¸¸ÅÀÚÀÇ Çù»ó·Â
  • ´ëüǰÀÇ À§Çù
  • ½Å±Ô Âü°¡¾÷üÀÇ À§Çù
  • °æÀï ±â¾÷°£ °æÀï °ü°è

Á¦5Àå ¼¼°èÀÇ ¸¶ÀÌÅ©·ÎÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ ½ÃÀå : Á¦Ç°º°

  • In-Vivo
  • In-Vitro

Á¦6Àå ¼¼°èÀÇ ¸¶ÀÌÅ©·ÎÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ ½ÃÀå : ÄÄÆ÷³ÍÆ®º°

  • °ËÃâ±â
  • X¼± ¼Ò½º
  • À̹ÌÁö À籸¼º ¼ÒÇÁÆ®¿þ¾î
  • Á¦¾î ¹× ºÐ¼® ¼ÒÇÁÆ®¿þ¾î
  • Äݸ®¸ÞÀÌÅÍ ¹× ÇÊÅÍ
  • ¾×¼¼¼­¸® ¹× ¼Ò¸ðǰ
  • ±âŸ ÄÄÆ÷³ÍÆ®

Á¦7Àå ¼¼°èÀÇ ¸¶ÀÌÅ©·ÎÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ ½ÃÀå : ¿ëµµº°

  • ½ÄǰÇÐ
  • ÁöÁúÁ¶»ç
  • ÀÇ·á±â±â
  • ¾Ï ¿¬±¸
  • ÷´Ü Àç·á
  • ÀÏ·ºÆ®·Î´Ð½º
  • Á¤Çü¿Ü°ú
  • ±âŸ ¿ëµµ

Á¦8Àå ¼¼°èÀÇ ¸¶ÀÌÅ©·ÎÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • È­»ó Áø´Ü ½ÇÇè½Ç
  • Ä¡°ú±â°ø¼Ò
  • Á¶»ç±â°ü
  • »ê¾÷
  • ±âŸ ÃÖÁ¾ »ç¿ëÀÚ

Á¦9Àå ¼¼°èÀÇ ¸¶ÀÌÅ©·ÎÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ ½ÃÀå : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ´ºÁú·£µå
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ³²¹Ì
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • Ä¥·¹
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • īŸ¸£
    • ³²¾ÆÇÁ¸®Ä«
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦10Àå ÁÖ¿ä ¹ßÀü

  • °è¾à/ÆÄÆ®³Ê½Ê/Çù¾÷/ÇÕÀÛÅõÀÚ(JV)
  • Àμö¿Í ÇÕº´
  • ½ÅÁ¦Ç° ¹ß¸Å
  • »ç¾÷ È®´ë
  • ±âŸ ÁÖ¿ä Àü·«

Á¦11Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • Baker Hughes Company
  • BehinNegareh
  • Bruker Corporation
  • Carl Zeiss AG
  • KA Imaging
  • MILabs BV
  • NeoScan
  • North Star Imaging Inc.
  • PerkinElmer
  • ProCon X-Ray GmbH
  • RX Solutions
  • Ray Co., Ltd
  • Rigaku Corporation
  • Sanying Precision Instruments Co. Ltd
  • SCANCO Medical AG
  • Shimadzu Corporation
  • TESCAN
  • Thermo Fisher Scientific
  • WENZEL Metrology GmbH
  • YXLON International GmbH
JHS 24.03.25

According to Stratistics MRC, the Global Micro Computed Tomography Market is accounted for $231.8 million in 2023 and is expected to reach $481.4 million by 2030 growing at a CAGR of 11.0% during the forecast period. Micro Computed Tomography (micro-CT) is a powerful 3D imaging technique that uses X-rays to generate detailed cross-sectional images of small objects. Micro-CT provides valuable insights into the internal structures of samples, aiding in research, quality control, and diagnostics. Its versatility makes it indispensable for studying materials, biological samples, and artifacts, contributing to advancements in science, medicine, and various industries.

According to Tescan, UniTOM HR is ideal for both industrial and academic researchers who want micro-CT imaging to examine a sample's internal structure as well as a deeper knowledge of the sample's behavior under various environmental circumstances.

Market Dynamics:

Driver:

Continuous advancements in Micro-CT technology

Ongoing innovations, including improved spatial resolution, faster imaging capabilities, and enhanced image quality, have expanded the application scope across industries. The market has experienced heightened demand as researchers and industries leverage the latest technological features for precise materials analysis, preclinical research, and non-destructive testing. Thus, the evolution of Micro-CT technology has not only addressed existing challenges but has also sparked new possibilities, fostering a dynamic landscape that attracts investments and promotes its integration as a vital imaging tool in various scientific and industrial domains.

Restraint:

Competition from alternative imaging technologies

Depending on specific requirements, users may opt for alternative modalities, potentially hindering Micro-CT adoption. Each imaging technology has its strengths and limitations, and the perceived advantages of alternatives may divert attention from Micro-CT. This competition may slow market growth, particularly in applications where alternative technologies offer advantages, affecting Micro-CT's market share and positioning impeding the market.

Opportunity:

Growing awareness of 3D imaging

As industries and research sectors recognize the advantages of detailed, high-resolution 3D visualization for accurate analysis of internal structures, the demand for Micro-CT has surged. Its widespread adoption in materials science, preclinical research, healthcare, and industrial applications reflects the pivotal role it plays in providing comprehensive insights. The heightened awareness has stimulated technological advancements and increased research funding, positioning Micro-CT as a key player in non-invasive imaging solutions across diverse fields.

Threat:

Limited field of view and sample size

Researchers and industries requiring comprehensive imaging of sizable samples may opt for alternative technologies, limiting Micro-CT adoption. The challenge of accommodating diverse sample sizes reduces the versatility of Micro-CT, affecting its competitiveness against imaging solutions capable of handling broader ranges of specimen dimensions hampering the market growth.

Covid-19 Impact

Disruptions in supply chains, project delays, and budget constraints have led to a slowdown in equipment purchases. With laboratories facing closures and prioritizing essential research, demand for non-urgent applications, like certain preclinical studies or materials research, has decreased. Travel restrictions also hindered on-site installations and maintenance. Economic uncertainties and reduced research funding further contributed to a challenging environment.

The geological studies segment is expected to be the largest during the forecast period

The geological studies segment is estimated to have a lucrative growth, due to driving demand for non-destructive imaging in analyzing rock and mineral structures. Micro-CT technology plays a crucial role in geological research, providing detailed 3D images for studying subsurface features, porosity, and composition. This application aids geoscientists in understanding geological formations, reservoir characterization, and environmental assessments boost the market growth.

The diagnostic imaging labs segment is expected to have the highest CAGR during the forecast period

The diagnostic imaging labs segment is anticipated to witness the highest CAGR growth during the forecast period, due to increasing demand for advanced imaging technologies. These labs leverage Micro-CT for precise and non-invasive imaging in fields such as medicine, dentistry, and preclinical research. The technology's ability to provide high-resolution 3D images contributes to diagnostic accuracy and research advancements, fostering growth in the market.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period due to increasing research activities, industrialization, and technological advancements. Countries like China, Japan, and South Korea are key contributors, driven by expanding applications in materials science, biomedical research, and industrial inspection. Overall, the Asia Pacific market is poised for continued development, fueled by a diverse range of applications across scientific disciplines and industries.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, owing to strong investments in R&D, especially in the United States and Canada, support innovation and technological advancements in Micro-CT systems. Industries, including aerospace and automotive, leverage Micro-CT for quality control and materials analysis. Despite challenges, the North America Micro-CT market is positioned for continued expansion, driven by a diverse range of applications.

Key players in the market

Some of the key players in the Micro Computed Tomography Market include Baker Hughes Company, BehinNegareh, Bruker Corporation, Carl Zeiss AG, K.A. Imaging, MILabs B.V., NeoScan , North Star Imaging Inc., PerkinElmer, ProCon X-Ray GmbH, R.X. Solutions, Ray Co., Ltd, Rigaku Corporation,Sanying Precision Instruments Co. Ltd, SCANCO Medical AG, Shimadzu Corporation, TESCAN, Thermo Fisher Scientific , WENZEL Metrology GmbH and YXLON International GmbH

Key Developments:

In January 2024, Biognosys Expands US Footprint with New Proteomics CRO Facility in Massachusetts, The Massachusetts facility will initially focus on TrueDiscovery® data-independent acquisition (DIA) discovery proteomics services that offer biopharma researchers

In December 2023, Baker Hughes an energy technology company announced a 20-year framework agreement with Chevron Australia Pty Ltd. Baker Hughes will offer its innovative Aptara Subsea production systems for Chevron Australia's future offshore developments.

In November 2023, Energy technology company Baker Hughes announced the launch of its new PythonPipe™ portfolio, the latest in reinforced thermoplastic pipe (RTP) technology that enables faster installation, reduced time to first production and lower lifecycle emissions.

Products Covered:

  • In-Vivo
  • In-Vitro

Components Covered:

  • Detector
  • X-ray Source
  • Image Reconstruction Software
  • Control & Analysis Software
  • Collimators & Filters
  • Accessories & Consumables
  • Other Components

Applications Covered:

  • Food Studies
  • Geological Studies
  • Medical Devices
  • Cancer Studies
  • Electronics
  • Other Applications

End Users Covered:

  • Diagnostic Imaging Labs
  • Dental Laboratories
  • Research Institutes
  • Industries
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Micro Computed Tomography Market, By Product

  • 5.1 Introduction
  • 5.2 In-Vivo
  • 5.3 In-Vitro

6 Global Micro Computed Tomography Market, By Component

  • 6.1 Introduction
  • 6.2 Detector
  • 6.3 X-ray Source
  • 6.4 Image Reconstruction Software
  • 6.5 Control & Analysis Software
  • 6.6 Collimators & Filters
  • 6.7 Accessories & Consumables
  • 6.8 Other Components

7 Global Micro Computed Tomography Market, By Application

  • 7.1 Introduction
  • 7.2 Food Studies
  • 7.3 Geological Studies
  • 7.4 Medical Devices
  • 7.5 Cancer Studies
  • 7.6 Advanced Materials
  • 7.7 Electronics
  • 7.8 Orthopedics
  • 7.9 Other Applications

8 Global Micro Computed Tomography Market, By End User

  • 8.1 Introduction
  • 8.2 Diagnostic Imaging Labs
  • 8.3 Dental Laboratories
  • 8.4 Research Institutes
  • 8.5 Industries
  • 8.6 Other End Users

9 Global Micro Computed Tomography Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Baker Hughes Company
  • 11.2 BehinNegareh
  • 11.3 Bruker Corporation
  • 11.4 Carl Zeiss AG
  • 11.5 K.A. Imaging
  • 11.6 MILabs B.V.
  • 11.7 NeoScan
  • 11.8 North Star Imaging Inc.
  • 11.9 PerkinElmer
  • 11.10 ProCon X-Ray GmbH
  • 11.11 R.X. Solutions
  • 11.12 Ray Co., Ltd
  • 11.13 Rigaku Corporation
  • 11.14 Sanying Precision Instruments Co. Ltd
  • 11.15 SCANCO Medical AG
  • 11.16 Shimadzu Corporation
  • 11.17 TESCAN
  • 11.18 Thermo Fisher Scientific
  • 11.19 WENZEL Metrology GmbH
  • 11.20 YXLON International GmbH
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦